Two echinocandin-resistant Candida glabrata FKS mutants from South Africa
Serisha D. Naicker, Rindidzani E. Magobo, Thokozile G. Zulu, Tsidiso G. Maphanga, Nkosinathi Luthuli, Warren Lowman, Nelesh P. Govender
Abstract
Open-access reader
Serisha D. Naicker, Rindidzani E. Magobo, Thokozile G. Zulu, Tsidiso G. Maphanga, Nkosinathi Luthuli, Warren Lowman, Nelesh P. Govender
Abstract
Open-access reader
Echinocandins are recommended as first-line agents to treat invasive infections caused by Candida glabrata since this organism is inherently less susceptible to azoles. However, resistance to echinocandins has been described in C. glabrata due to amino acid changes in the hotspot regions of the FKS1 and FKS2 genes. In this report, we describe the first two South African C. glabrata isolates with echinocandin resistance mediated by mutations in the FKS2 gene. Both isolates were cultured from urine specimens from private-sector patients.
OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Echinocandins are recommended as first-line agents to treat invasive infections caused by Candida glabrata since this organism is inherently less susceptible to azoles. However, resistance to echinocandins has been described in C. glabrata due to amino acid changes in the hotspot regions of the FKS1 and FKS2 genes. In this report, we describe the first two South African C. glabrata isolates with echinocandin resistance mediated by mutations in the FKS2 gene. Both isolates were cultured from urine specimens from private-sector patients.
Key concepts: Candida glabrata, Echinocandins, Echinocandin, Microbiology, Medicine, Mutant, Gene, Biology